CUE-201

N/A

Report date: 2025/01/26 18:26:49

Base Information

Drug NameCUE-201
Drug Alias NameCUE-200 series (Cue Biopharma)T-cell receptor targeting complex-CD80-4-1BBL fusion protein (Cue Biopharma)peptide-MHC-CD80-4-1BBL fusion protein (Cue Biopharma)triple tumor antigen-MHC complex/CD28 costimulator/4-1BB costimulator Cue BiopharmaCUE-201
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionTumor necrosis factor receptor superfamily member 9 stimulantsT-cell receptor agonistsT-cell-specific surface glycoprotein CD28 agonists
TargetsT-cell-specific surface glycoprotein CD28T-cell receptorTumor necrosis factor receptor superfamily member 9
Therapy Area/IndicationsCommunicable Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCue Biopharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesCue Biopharma Inc
Inactive CompaniesN/A
Active IndicationsCommunicable Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A